title: Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments?
authors.affiliation: Institute for Drug Development, Cancer Therapy and Research Center, Alice P McDermott Building, San Antonio, TX 78245-3217, USA. ctakimot@idd.org
authors.forename: Chris H
authors.initials: CH
authors.lastname: Takimoto